MedPath
HSA Approval

COSPAN INJ. 20 mg/ml

SIN03683P

COSPAN INJ. 20 mg/ml

COSPAN INJ. 20 mg/ml

September 18, 1989

ZYFAS PHARMA PTE LTD

ZYFAS PHARMA PTE LTD

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantZYFAS PHARMA PTE LTD
Licence HolderZYFAS PHARMA PTE LTD

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

INJECTION

INTRAVENOUS, INTRAMUSCULAR

Medical Information

A03BB01

butylscopolamine

Manufacturer Information

ZYFAS PHARMA PTE. LTD.

SAMJIN PHARMACEUTICAL CO LTD

Active Ingredients

HYOSCINE BUTYLBROMIDE

20 mg/ml

Hyoscine butylbromide

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

COSPAN INJ. 20 mg/ml - HSA Approval | MedPath